HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nguyen, T. Articles by Dong, C. Search for Related Content PubMed PubMed Citation Articles by Nguyen, T. Articles by Dong, C.

BTNL2, a Butyrophilin-Like Molecule That Functions to Inhibit T Cell Activation¹

Thang Nguyen^2,*, Xikui K. Liu^2,, Yongliang Zhang and Chen Dong^3,

^* Department of Immunology, University of Washington School of Medicine, Seattle, WA 98195; and Department of Immunology, M. D. Anderson Cancer Center, Houston, TX 77030

B7 family members regulate T cell activation and tolerance. Although butyrophilin proteins share sequence homology with the B7 molecules, it is unclear whether they have any function in immune responses. In the present study, we characterize an MHC class II gene-linked butyrophilin family member, butyrophilin-like 2 (BTNL2), the mutation of which has been recently associated with the inflammatory autoimmune diseases sarcoidosis and myositis. Mouse BTNL2 is a type I transmembrane protein with two pairs of Ig-like domains separated by a heptad peptide sequence. BTNL2 mRNA is highly expressed in lymphoid tissues as well as in intestine. To characterize the function of BTNL2, we produced a BTNL2-Ig fusion protein. It recognized a putative receptor whose expression on B and T cells was significantly enhanced after activation. BTNL2-Ig inhibited T cell proliferation and TCR activation of NFAT, NF-B, and AP-1 signaling pathways. BTNL2 is thus the first member of the butyrophilin family that regulates T cell activation, which has implications in immune diseases and immunotherapy.

This article has been cited by other articles:

				J. Jeong, A. U. Rao, J. Xu, S. L. Ogg, Y. Hathout, C. Fenselau, and I. H. Mather The PRY/SPRY/B30.2 Domain of Butyrophilin 1A1 (BTN1A1) Binds to Xanthine Oxidoreductase: IMPLICATIONS FOR THE FUNCTION OF BTN1A1 IN THE MAMMARY GLAND AND OTHER TISSUES J. Biol. Chem., August 14, 2009; 284(33): 22444 - 22456. [Abstract] [Full Text] [PDF]

				G. Malcherek, L. Mayr, P. Roda-Navarro, D. Rhodes, N. Miller, and J. Trowsdale The B7 Homolog Butyrophilin BTN2A1 Is a Novel Ligand for DC-SIGN J. Immunol., September 15, 2007; 179(6): 3804 - 3811. [Abstract] [Full Text] [PDF]

				Y. Yang, X. K. Liu, T. Nguyen, C. Bishop, D. Graf, and C. Dong Characterization of B7S3 as a Novel Negative Regulator of T Cells J. Immunol., March 15, 2007; 178(6): 3661 - 3667. [Abstract] [Full Text] [PDF]

				H. A. Arnett, S. S. Escobar, E. Gonzalez-Suarez, A. L. Budelsky, L. A. Steffen, N. Boiani, M. Zhang, G. Siu, A. W. Brewer, and J. L. Viney BTNL2, a Butyrophilin/B7-Like Molecule, Is a Negative Costimulatory Molecule Modulated in Intestinal Inflammation J. Immunol., February 1, 2007; 178(3): 1523 - 1533. [Abstract] [Full Text] [PDF]